Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

Published Date: 10 Sep 2025

A randomized Phase II trial from National Taiwan University Hospital reports early evidence that resecting the primary thoracic tumor following EGFR tyrosine kinase inhibitor (TKI) therapy may prolong disease control in patients ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

2.

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

3.

Understudied mental health challenges among caregivers of cancer patients: A call for targeted support

4.

A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.

5.

According to a study, taking part in a clinical trial for cancer may not actually increase survival.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot